Michael Mueller is listed as a director on 3 SEC Form D filings by 2 issuers between Oct 2018 and Mar 2020: Pediapharm Inc. (Verdun, Quebec, Canada (as filed: A8) — pharmaceuticals — 2018; $7.67M reported sold to 2 investors) and Medexus Pharmaceuticals Inc. (Verdun, Quebec, Canada (as filed: A8) — pharmaceuticals — 2020; $400K reported sold to 1 investors).
What this means 2 separate companies raised money with this person listed as director, over about 2 years. Across those companies the filings report $8.07M sold in total.
Listed alongside Benoit Gravel (3 shared filings), Roland Boivin (3 shared filings), Normand Chartrand (2 shared filings), Pierre Lapalme (2 shared filings), Sylvain Chretien (2 shared filings) and 5 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Michael. Each name links to their own page.
All 2 issuers belong to the sponsor group Pediapharm (2 issuers, $496K reported sold, 2018–2020).
What this means A sponsor group is one team that sets up a new company for each deal. Pediapharm has 2 companies on file and $496K reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA) — 1 SEC release listed in Key records below.
What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 3 public filings for Michael Mueller and found 7 differences: Michael Mueller appears on 1 deal that stopped filing before reaching its target; No amendment in the last 12 months on an offering that may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.